| Targeted therapies in pulmonary arterial hypertension D Montani, MC Chaumais, C Guignabert, S Günther, B Girerd, X Jaïs, ... Pharmacology & therapeutics 141 (2), 172-191, 2014 | 244 | 2014 |
| Extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest: a registry study W Bougouin, F Dumas, L Lamhaut, E Marijon, P Carli, A Combes, ... European heart journal 41 (21), 1961-1971, 2020 | 227 | 2020 |
| The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis J Heijman, V Algalarrondo, N Voigt, J Melka, XHT Wehrens, D Dobrev, ... Cardiovascular research 109 (4), 467-479, 2016 | 219 | 2016 |
| Genotype–phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France LL Mariani, P Lozeron, M Théaudin, Z Mincheva, A Signate, B Ducot, ... Annals of neurology 78 (6), 901-916, 2015 | 167 | 2015 |
| Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double … JP Piccini, V Caso, SJ Connolly, KAA Fox, J Oldgren, WS Jones, ... The lancet 399 (10333), 1383-1390, 2022 | 163 | 2022 |
| Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study E Marijon, C Leclercq, K Narayanan, S Boveda, D Klug, ... European heart journal 36 (41), 2767-2776, 2015 | 120 | 2015 |
| Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study D Adams, M Polydefkis, A González-Duarte, J Wixner, AV Kristen, ... The Lancet Neurology 20 (1), 49-59, 2021 | 115 | 2021 |
| FAP neuropathy and emerging treatments D Adams, M Théaudin, C Cauquil, V Algalarrondo, M Slama Current Neurology and Neuroscience Reports 14, 1-12, 2014 | 105 | 2014 |
| Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: focus on idiopathic ventricular fibrillation V Waldmann, W Bougouin, N Karam, F Dumas, A Sharifzadehgan, ... European Heart Journal 39 (21), 1981-1987, 2018 | 98 | 2018 |
| Prophylactic pacemaker implantation in familial amyloid polyneuropathy V Algalarrondo, S Dinanian, C Juin, D Chemla, SL Bennani, C Sebag, ... Heart Rhythm 9 (7), 1069-1075, 2012 | 98 | 2012 |
| Extreme bradycardia after first doses of sofosbuvir and daclatasvir in patients receiving amiodarone: 2 cases including a rechallenge S Renet, MC Chaumais, T Antonini, A Zhao, L Thomas, A Savoure, ... Gastroenterology 149 (6), 1378-1380. e1, 2015 | 95 | 2015 |
| Right atrial mechanisms of atrial fibrillation in a rat model of right heart disease R Hiram, P Naud, F Xiong, D Al-u’datt, V Algalarrondo, MG Sirois, ... Journal of the American College of Cardiology 74 (10), 1332-1347, 2019 | 92 | 2019 |
| Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis D Hamon, V Algalarrondo, E Gandjbakhch, F Extramiana, E Marijon, ... International journal of cardiology 222, 562-568, 2016 | 87 | 2016 |
| Should we perform an immediate coronary angiogram in all patients after cardiac arrest? Insights from a large French registry W Bougouin, F Dumas, N Karam, C Maupain, E Marijon, L Lamhaut, ... JACC: Cardiovascular Interventions 11 (3), 249-256, 2018 | 69 | 2018 |
| TTR kinetic stabilizers and TTR gene silencing: a new era in therapy for familial amyloidotic polyneuropathies D Adams, C Cauquil, C Labeyrie, G Beaudonnet, V Algalarrondo, ... Expert opinion on pharmacotherapy 17 (6), 791-802, 2016 | 64 | 2016 |
| Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry G Boriani, M Proietti, C Laroche, L Fauchier, F Marin, M Nabauer, ... EP Europace 21 (7), 1013-1022, 2019 | 61 | 2019 |
| Primary prevention implantable cardioverter defibrillator (ICD) therapy in women—data from a multicenter French registry R Providência, E Marijon, PD Lambiase, A Bouzeman, P Defaye, D Klug, ... Journal of the American Heart Association 5 (2), e002756, 2016 | 59 | 2016 |
| Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1 K Wahbi, V Algalarrondo, HM Bécane, V Fressart, C Beldjord, K Azibi, ... Archives of cardiovascular diseases 106 (12), 635-643, 2013 | 56 | 2013 |
| Cardiac overexpression of PDE4B blunts β-adrenergic response and maladaptive remodeling in heart failure S Karam, JP Margaria, A Bourcier, D Mika, A Varin, I Bedioune, M Lindner, ... Circulation 142 (2), 161-174, 2020 | 50 | 2020 |
| Association between mutation size and cardiac involvement in myotonic dystrophy type 1: an analysis of the DM1-heart registry C Chong-Nguyen, K Wahbi, V Algalarrondo, HM Bécane, ... Circulation: Cardiovascular Genetics 10 (3), e001526, 2017 | 47 | 2017 |
Eloi Marijon, MD, PhDUniversité Paris Cité & European G. Pompidou HospitalVerifisert e-postadresse på u-paris.fr
